argenx vs Boston Scientific

argenx (ARGX), health care, and Boston Scientific (BSX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Boston Scientific is worth $62.6B on the stock market and argenx $59.4B: Boston Scientific is valued at 5% more. argenx trades at 32.7 times earnings and Boston Scientific at 18.2; operating margins in their latest fiscal years were 25.4% and 18.0%. Over the past year argenx's share price has moved +3.53% and Boston Scientific's -56.0%.

Key facts

argenx market value
$59.4B
Boston Scientific market value
$62.6B
argenx P/E
32.7
Boston Scientific P/E
18.2
argenx revenue
$4.2BFY to 2025-12-31
Boston Scientific revenue
$20.1BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

argenx vs Boston Scientific: every measure side by side
Measure argenx Boston Scientific
SectorHealth CareHealth Care
Country Belgium United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$59.4Blower$62.6Bhigher
Revenue$4.2Blower$20.1Bhigher
Earnings$1.3Blower$2.9Bhigher
Employees1,863lower59,000higher
Total assets$8.7Blower$43.7Bhigher
Valuation
P/E32.7higher18.2lower
P/S14.3higher3.1lower
P/B—2.4
Dividend yield—0.00%
Profitability
Operating margin25.4%higher18.0%lower
Balance sheet
Net assets$7.3Blower$24.2Bhigher
Total liabilities$1.4Blower$19.2Bhigher
Total debt—$11.4B
Cash on hand$3.5Bhigher$2Blower
Price change
Today-0.62%higher-1.09%lower
1 year+3.53%higher-56.0%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio. Who owns ARGX · Who owns BSX

Further comparisons

Learn

Questions and answers

Which is bigger, argenx or Boston Scientific?

By market value, Boston Scientific is the larger: $62.6B against $59.4B for argenx. By revenue in its latest fiscal year, Boston Scientific is the larger: $20.1B against $4.2B for argenx.

Which has the higher P/E ratio?

argenx: 32.7, against 18.2 for Boston Scientific. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

argenx: 25.4%, against 18.0% for Boston Scientific. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which superinvestors own both argenx and Boston Scientific?

None of the tracked superinvestors holds both in their latest 13F filing. 2 hold argenx and 13 hold Boston Scientific.

Cite this page

Funkfolio, “argenx vs Boston Scientific”, data as of 17 November 2026. https://funkfolio.com/compare/argx-vs-bsx

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.